Mencari ubat atas namanya

Bisoprolol dan PVD

Hasil ujian interaksi ubat Bisoprolol dan penyakit PVD untuk kontraindikasi dan kesan sampingan dengan penggunaan bersama.

Hasil pemeriksaan:

Bisoprolol <> PVD

Relevan: 23.07.2019 Pengulas: MD P.M. Shkutko, in

Kontraindikasi atau kesan sampingan yang boleh membahayakan atau meningkatkan kesan negatif apabila menggunakan ubat dengan penyakit ditemui saat pemeriksaan interaksi mengikut sumber yang bereputasi - Drugs.com, RXList.com, Webmd.com, MedScape.com.

Pengguna:

Kerana mereka negatif inotropic dan chronotropic kesan pada jantung, beta-adrenergic reseptor menyekat agen (aka beta-blocker) menurunkan output jantung dan mungkin mengendapkan atau memburukkan gejala kekurangan arteri dalam pasien dengan pinggiran vaskular penyakit. Di samping itu, nonselective beta-blocker (contohnya, propranolol, pindolol, timolol) mungkin melemahkan catecholamine-diselesaikan vasodilatasi semasa latihan dengan menyekat beta-2 reseptor di pinggir kapal. Terapi dengan beta-blocker perlu diberikan berhati-hati pesakit dengan pinggiran vaskular penyakit. Tutup memantau perkembangan halangan arteri dinasihatkan.

Sumber

"Product Information. Cartrol (carteolol)." Abbott Pharmaceutical, Abbott Park, IL.
Coppeto JR "Transient ischemic attacks and amaurosis fugax from timolol." Ann Ophthalmol 17 (1985): 64-5
Broeder CE, Thomas EL, Martin NB, Hofman Z, Jesek JK, Scruggs KD, Wambsgans KC, Wilmore JH "Effects of propranolol and pindolol on cardiac output during extended periods of low-intensity physical activity." Am J Cardiol 72 (1993): 1188-95
Michelson EL, Frishman WH, Lewis JE, et al "Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension." Am J Med Oct 17 (1983): 68-80
"Product Information. Trandate (labetalol)." Glaxo Wellcome, Research Triangle Park, NC.
"Product Information. Lopressor (metoprolol)." Novartis Pharmaceuticals, East Hanover, NJ.
Breckenridge A, Roberts DH "Antihypertensive treatment in concomitant peripheral vascular disease: current experience and the potential of carvedilol." J Cardiovasc Pharmacol 18 Suppl 4 (1991): s78-81
"Product Information. Sectral (acebutolol)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Lepantalo M "Beta blockade and intermittent claudication." Acta Med Scand 700 (1985): 1-48
"Product Information. Kerlone (betaxolol)." Searle, Skokie, IL.
Mashford ML, Coventry D, Hecker R, et al. "Adverse Drug Reactions Advisory Committee: ADRAC report for 1980." Med J Aust 1 (1982): 416-9
"Product Information. Zebeta (bisoprolol)." Lederle Laboratories, Wayne, NJ.
Eliasson K, Lins L-E, Sundqvist K "Peripheral vasospasm during beta-receptor blockade: a comparison between metoprolol and pindolol." Acta Med Scand 665 (1982): 109-12
"Product Information. Blocadren (timolol)." Merck & Co, Inc, West Point, PA.
"Product Information. Visken (pindolol)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
"Product Information. Levatol (penbutolol)." Reed and Carnrick, Jersey City, NJ.
Eliasson K, Danielson M, Hylander B, Lindblad LE "Raynaud's phenomenon caused by beta-receptor blocking drugs." Acta Med Scand 215 (1984): 333-9
"Product Information. Normodyne (labetalol)." Schering Laboratories, Kenilworth, NJ.
"Product Information. Inderal (propranolol)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Holti G "A double-blind study of the peripheral vasoconstrictor effects of the beta-blocking drug penbutolol in patients with Raynaud's phenomenon." Curr Med Res Opin 6 (1979): 267-70
"Product Information. Tenormin (atenolol)." ICN Pharmaceuticals Inc, Cost Mesa, CA.
"Product Information. Corgard (nadolol)." Bristol-Myers Squibb, Princeton, NJ.
Tcherdakoff P "Side-effects with long-term labetalol: an open study of 251 patients in a single centre." Pharmatherapeutica 3 (1983): 342-8
Myers J, Morgan T, Waga S, et al "Long-term experiences with labetalol." Med J Aust 1 (1980): 665-6
"Product Information. Betapace (sotalol)." Berlex, Richmond, CA.